Skip links and keyboard navigation

Recent summary of changes to the LAM

The tables below show a summary of changes to the list of approved medicines (LAM) since it was last published. The LAM is published monthly or more frequently if required.


Faricimab intraocular injection 6mg/0.05mL, vial
Phenol injection 5% in Oil 5mL


Ruxolitinib tablet 5mg, 10mg
Ruxolitinib tablet 15mg, 20mg
Sotrovimab injection 500mg/8mL
Casirivimab + imdevimab (Ronapreve®) injection 120 mg/mL + 120 mg/mL
Remdesivir injection 100mg/20mL
Baricitinib tablet 2mg, 4mg
Molnupiravir capsule 200mg
Nirmatrelvir + ritonavir tablets 150mg + 100mg (Paxlovid®)
Tocilizumab injection 80mg/4mL, 200mg/10mL, 400mg/20mL
Etanercept injection 50mg (pre-filled syringe, auto-injector)


Fiasp (insulin aspart – fast acting) injection 100 units/mL, 3mL pen device and 10mL vial
Hydromorphone modified release (MR) tablets 4mg, 8mg, 16mg, 32mg, 64mg
Last updated: 5 June 2023